Pipeline
Intervacc’s developmental program for new vaccines against animal infectious diseases is summarised in the following table. Please, click on respective project name or indication to read more.
| Project | Disease area | Species | Preclinical | Clinical | Regulatory | Market |
|---|---|---|---|---|---|---|
| Strangvac® | Strangles | Horse | ||||
| INV274 | Strep. suis infection | Piglets | ||||
| INV412 | Staph. aureus mastitis | Cow |
The successful clinical trials with vaccination against strangles using Strangvac®, based on fusions of recombinant proteins, demonstrates that our technology can be applied also for development of other vaccines.